Pharmacological and non‐pharmacological interventions for managing sleep disorders in children with cerebral palsy: A systematic review
Developmental Medicine & Child Neurology · 21.08.2026
DOI: 10.1111/dmcn.70435 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 21.08.2026. Verfasst von Nishant Jaiswal und 11 weiteren Autor:innen. Beteiligte Einrichtung: NIHR Evidence Synthesis Group @Complex Review Synthesis Unit, UK. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
To systematically review the effectiveness, safety, and economic evidence of pharmacological and non‐pharmacological interventions for sleep disorders in children with cerebral palsy (CP).
Method
Databases including MEDLINE, Embase, CENTRAL (the Cochrane Library), International Clinical Trials Registry Platform of the World Health Organization, NHS Economic Evaluation Database, and ClinicalTrials.gov were searched up to May 2026. Randomized controlled trials and economic evaluations were eligible. Primary outcomes included sleep quality, adverse events, and tolerability. We incorporated interest holder perspectives, including clinicians and individuals with lived experience, throughout outcome prioritization and interpretation. We assessed risk of bias using the Cochrane Risk of Bias 2.0 tool and evaluated the certainty of evidence using Grades of Recommendation, Assessment, Development and Evaluation.
Results
Twelve randomized controlled trials ( n = 19–142, aged 5–17 years) were included. Pharmacological (melatonin, cannabis‐based medicines, baclofen, neural stem cells) and non‐pharmacological interventions (massage, cranial osteopathy, music therapy, acupuncture, postural support) were evaluated. Melatonin improved sleep latency and duration modestly compared with placebo. Other interventions showed inconsistent or negligible effects. Adverse events were mild and tolerability acceptable. No completed economic evaluations were identified. Interest holders highlighted the multifactorial nature of sleep problems, the need for interventions addressing comorbidities, and improved reporting of equity factors.
Interpretation
Evidence for managing sleep disorders in children with CP is limited, heterogeneous, and of low certainty. Robust trials and economic evaluations are urgently needed.
Autor:innen und Institutionen
- NIHR Evidence Synthesis Group @Complex Review Synthesis Unit, UK.
- Health Economics and Health Technology Assessment (HEHTA), School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
- Department of Population Health Sciences, University of Leicester, Leicester, UK.
- The Cochrane Collaboration, London, UK.
- Cerebral Palsy Scotland, Glasgow, UK.
- Royal Hospital for Children, Glasgow, UK.
ORCID-Profile: Nishant Jaiswal, Lizzie Fisher
Zitieren
APA
Jaiswal, N., Fisher, L., Ciminata, G., Mulholland, R., Noel-Storr, A., Nutton, L., Orr, V., Eunson, P., Cooper, N. J., Sutton, A., Wu, O., & Quinn, T. (2026). Pharmacological and non‐pharmacological interventions for managing sleep disorders in children with cerebral palsy: A systematic review. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70435
Vancouver
Jaiswal N, Fisher L, Ciminata G, Mulholland R, Noel-Storr A, Nutton L, et al. Pharmacological and non‐pharmacological interventions for managing sleep disorders in children with cerebral palsy: A systematic review. Developmental Medicine & Child Neurology. 2026. doi:10.1111/dmcn.70435
BibTeX
@article{Jaiswal2026,
author = {Jaiswal, Nishant and Fisher, Lizzie and Ciminata, Giorgio and Mulholland, Ryan and Noel-Storr, Anna and Nutton, Lesley and Orr, Valerie and Eunson, Paul and Cooper, Nicola J and Sutton, Alex and Wu, Olivia and Quinn, Terry},
title = {Pharmacological and non‐pharmacological interventions for managing sleep disorders in children with cerebral palsy: A systematic review},
journal = {Developmental Medicine & Child Neurology},
year = {2026},
doi = {10.1111/dmcn.70435}
}
EUVIMED